Blog & News
Stay up to date with MaxWell Biosystems.
Explore our latest posts: science highlights, publications, and ideas from the people behind MaxWell.
Guided by engineering excellence, integrity, and customer impact, we share insights that support better research.
Closed-loop training of organoids to balance a Cartpole (Inverted Pendulum)
%2520Li.avif)
Can living cortical organoids learn a control task? Robbins et al. show they can, balancing a cartpole via real-time, closed-loop stimulation on MaxOne HD-MEAs.
Mapping Neuronal Diversity: Functional Validation of Induced Neurons with HD-MEAs and DeePhys
Dive into a Science validating induced-neuron diversity by linking transcriptomics to electrophysiology with MaxTwo + DeePhys.
MaxWell Biosystems Launches Commercial Expansion: Strengthening Regional Presence in EMEA
MaxWell Biosystems AG is advancing its global go-to-market strategy with the establishment of a dedicated EMEA regional team, expanding its presence and partnerships across Europe, the Middle East, and Africa.
New Therapeutic Target in the Fight Against ALS
A Nature study presents a human iPSC-derived neuronal network model that reveals how TDP-43 dysfunction drives neurotoxicity in ALS/FTLD and highlights NPTX2 as a promising therapeutic target. Using MaxWell Biosystems' MaxOne HD-MEAs, the team captured high-resolution functional readouts of these networks, supporting detailed characterization from network down to single-cell features.
Closed-loop training of organoids to balance a Cartpole (Inverted Pendulum)
Can living cortical organoids learn a control task? Robbins et al. show they can, balancing a cartpole via real-time, closed-loop stimulation on MaxOne HD-MEAs.
Mapping Neuronal Diversity: Functional Validation of Induced Neurons with HD-MEAs and DeePhys
Dive into a Science validating induced-neuron diversity by linking transcriptomics to electrophysiology with MaxTwo + DeePhys.
New Therapeutic Target in the Fight Against ALS
A Nature study presents a human iPSC-derived neuronal network model that reveals how TDP-43 dysfunction drives neurotoxicity in ALS/FTLD and highlights NPTX2 as a promising therapeutic target. Using MaxWell Biosystems' MaxOne HD-MEAs, the team captured high-resolution functional readouts of these networks, supporting detailed characterization from network down to single-cell features.
MaxWell Biosystems Launches Commercial Expansion: Strengthening Regional Presence in EMEA
MaxWell Biosystems AG is advancing its global go-to-market strategy with the establishment of a dedicated EMEA regional team, expanding its presence and partnerships across Europe, the Middle East, and Africa.